Ruchi Bansal

Ruchi Bansal is an Associate Professor at the University of Twente, affiliated with the TechMed Centre and the Department of Medical Cell BioPhysics. She established the Translational Liver Research group in 2016 to develop targeted nanotherapeutics for liver diseases and cancer.

• PhD in Pharmacokinetics, Toxicology and Targeting, University of Groningen (2012)
• Postdoctoral Fellow at Karolinska Institute (2012-2014)
• Assistant Professor at University of Twente (2016-present)

Research Focus: Targeted drug delivery for chronic liver diseases (fibrosis, cancer), macrophage immunomodulation, and nanotechnology applications in fibrosis and tumor microenvironment. Her work aligns with UN Sustainable Development Goals related to health and innovation.

Key Publications highlight advancements in CCR8 antagonists for liver injury, SPIONs for fibrosis, and 3D bioprinted models for tumor-stroma interactions. Articles span 2025–2004, with recent emphasis on innate immune sexual dimorphism and epigenetic regulation in liver pathogenesis.

• Scientific Awards: EASL Young Investigator Bursary (2013, 2014), Hind Ratan Award (2019), LPDP Fellowship (2015), Junior Scholar Award (2015)

Collaborations extend across Europe and India, focusing on hepatocellular carcinoma, prostate cancer, and fibrosis biomarkers. She serves on editorial boards and participates in international conferences as invited speaker.